Nom du produit:2-(benzotriazol-1-ylmethyl)-3,4-dihydro-1H-isoquinoline
IUPAC Name:2-[(1H-1,2,3-benzotriazol-1-yl)methyl]-1,2,3,4-tetrahydroisoquinoline
- CAS:147676-25-3
- Formule moléculaire:C16H16N4
- Pureté:95%+
- Numéro de catalogue:CM708407
- Poids moléculaire:264.33
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:147676-25-3
- Formule moléculaire:C16H16N4
- Point de fusion:-
- Code SMILES:C(N1N=NC2=CC=CC=C12)N1CCC2=C(C1)C=CC=C2
- Densité:
- Numéro de catalogue:CM708407
- Poids moléculaire:264.33
- Point d'ébullition:
- N° Mdl:MFCD00963710
- Stockage:
Category Infos
- Tetrahydroisoquinolines
- Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.
- Benzotriazoles
- Benzotriazole is a bicyclic nitrogen heterocycle formed by the fusion of the benzene ring with the 4,5-positions or the “d” site of 1H-1,2,3-triazole. The benzotriazoles are known as important intermediates in the preparation of organic products such as β-amido ketones, aldehydes, β-ketoesters, ionic liquid, and as reagents for acylation and thioacylation reactions. 1H-Benzotriazoles are also known to exhibit broad spectrum of pharmacological activities. There are numerous benzotriazole-based clinically used drugs in the market for the treatment of various diseases.